Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure
In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69
Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse
DCPC Developing Hispanic Cancer Control Intervention Program Concept
Boston Meeting To Look At “IRBs At Crsswoad”
Trending Stories
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
- To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements









